Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Complex Generics And Biosimilars Drive First-Half Growth For Stada
As CEO Goldschmidt Acknowledges Company Owners Are Still Considering Options
Aug 29 2024
•
By
Dave Wallace
Stada reports its first-half results for 2024 • Source: Shutterstock
More from Earnings
More from Business